DeCell Technologies

Manufacturing · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

610 Hemlock Dr, Upper Tantallon, Nova Sc...

Phone Number

(902) 494-3015

Revenue

<$5 Million

Industry

Manufacturing Medical Devices & Equipment
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About DeCell Technologies

DeCell Technologies specializes in a patented human dermal matrix designed for difficult-to-heal wounds. Their product, DermGEN, is clinically proven to facilitate healing with a natural structure that promotes tissue regeneration and requires no preparation for application. The matrix is safe, self-adhering, and has shown effective results in clinical trials, with an average closure time of three weeks and no reported cases of infection. The company targets healthcare providers and institutions looking for advanced wound care solutions.Explore more
Popular SearchesDeCell Technologies IncDeCell TechnologiesDecelltechnologiesSIC Code 38,384NAICS Code 33,339Show more

DeCell Technologies Org Chart

Sean Margueratt, Co-Founder & Chief Executive Officer at DeCell Technologies
Canada flag for contact location.

Co-Founder & Chief Executive Officer

PhoneEmail
DM
Canada flag for contact location.

Clinical Specialist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is DeCell Technologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to DeCell Technologies

Compare insights from companies similar to DeCell Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

DeCell Technologies

<$5M
11-50
Private
-
2000
Sean Margueratt, Co-Founder & Chief Executive Officer at DeCell Technologies
Sean MarguerattCo-Founder & CEO
$7.1M
11-50
Private
-
1979
<$5M
11-50
Private
-
2008
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
2004
<$5M
1-10
Private
-
-
DB
Daniela BaiasCompany Owner
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

DeCell Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

DeCell Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DeCell Technologies.

DeCell Technologies Tech Stack

A closer look at the technologies used by DeCell Technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding DeCell Technologies

What is DeCell Technologies's official website?
DeCell Technologies's official website is www.decelltechnologies.com
What is DeCell Technologies's Revenue?
DeCell Technologies's revenue is <$5 Million
What is DeCell Technologies's SIC code?
DeCell Technologies's SIC: 38,384
What is DeCell Technologies's NAICS code?
DeCell Technologies's NAICS: 33,339
How many employees does DeCell Technologies have?
DeCell Technologies has 11-50 employees
What industry does DeCell Technologies belong to?
DeCell Technologies is in the industry of: Manufacturing, Medical Devices & Equipment
What is DeCell Technologies competition?
DeCell Technologies top competitors include: Dormer Laboratories, D & G Skin Care and Laser, Dermaspark Products, Kimera Scientific
What technology does DeCell Technologies use?
Some of the popular technologies that DeCell Technologies uses are: Sentry, Google Cloud Web Serving, Google Cloud Platform, F5 BIG-IP Platform
How do I contact DeCell Technologies?
DeCell Technologies contact info: Phone number: (902) 494-3015 Website: www.decelltechnologies.com
What does DeCell Technologies do?

DeCell Technologies specializes in a patented human dermal matrix designed for difficult-to-heal wounds. Their product, DermGEN, is clinically proven to facilitate healing with a natural structure that promotes tissue regeneration and requires no preparation for application. The matrix is safe, self-adhering, and has shown effective results in clin... ical trials, with an average closure time of three weeks and no reported cases of infection. The company targets healthcare providers and institutions looking for advanced wound care solutions.Read More

Is DeCell Technologies a public company?
DeCell Technologies is private company therefore does not currently have an official ticker symbol
See more information about DeCell Technologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.